tirzepatide for heart failure with preserved ejection fraction and obesity 60-Second Journal Club: The SUMMIT trial examined cardiovascular outcomes of treatment in patients with with obesity. Read the full trial Tirzepatide benefits obese HFpEF patients
Pay in 4 interest-free payments of $6.35 Learn more
Shipping Estimate
USA
- USA
- CAN
- USA
- CAN
Ships within 48 hours · Estimated delivery Aug 29 - Sep 3
























